Prosecution Insights
Prosecution Insights
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| No statute on record | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HOPKINS, SAMANTHA LAKE | 1 | 57.9% | +61.5% |
| BALLARD, KIMBERLY | 1 | 53.7% | +48.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17636699 | ANTI-CD19 ANTIBODIES AND USES THEREOF | HOPKINS, SAMANTHA LAKE | 168d overdue |
| 17634688 | ENGINEERED INTERLEUKIN-2 RECEPTOR BETA AGONISTS | BALLARD, KIMBERLY | 9d overdue |
| Art Unit | Apps |
|---|---|
| 1641 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17636699 | ANTI-CD19 ANTIBODIES AND USES THEREOF | HOPKINS, SAMANTHA LAKE | 1641 | — | Non-Final OA | 168d overdue | Pending | Feb 18, 2022 |
| 17634688 | ENGINEERED INTERLEUKIN-2 RECEPTOR BETA AGONISTS | BALLARD, KIMBERLY | 1675 | Other | Non-Final OA | 9d overdue | Pending | Feb 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial